NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,558 | +10.6% | 1,321 | +9.5% | 0.04% | +6.1% |
| Q2 2023 | $121,698 | +10.1% | 1,206 | +6.8% | 0.03% | +6.5% |
| Q1 2023 | $110,507 | -1.0% | 1,129 | -8.4% | 0.03% | 0.0% |
| Q4 2022 | $111,660 | +26.9% | 1,233 | +6.1% | 0.03% | +6.9% |
| Q3 2022 | $88,000 | -50.6% | 1,162 | -43.9% | 0.03% | -45.3% |
| Q2 2022 | $178,000 | -16.4% | 2,073 | -14.4% | 0.05% | -10.2% |
| Q1 2022 | $213,000 | +59.0% | 2,421 | +57.9% | 0.06% | +47.5% |
| Q4 2021 | $134,000 | +8.9% | 1,533 | +2.1% | 0.04% | -7.0% |
| Q3 2021 | $123,000 | -0.8% | 1,502 | +10.7% | 0.04% | -4.4% |
| Q2 2021 | $124,000 | +12.7% | 1,357 | +5.4% | 0.04% | +2.3% |
| Q1 2021 | $110,000 | +25.0% | 1,288 | +38.8% | 0.04% | +2.3% |
| Q4 2020 | $88,000 | +158.8% | 928 | +140.4% | 0.04% | +138.9% |
| Q3 2020 | $34,000 | +385.7% | 386 | +407.9% | 0.02% | +350.0% |
| Q2 2020 | $7,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |